The Veterans Affairs Pentoxifylline in Diabetic Kidney Disease (VA PTXRx) Study: Baseline Characteristics
Journal of the American Society of Nephrology · 2026-10 · 37 (10S)
DOI: 10.1681/asn.20268ctbde3b ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, 2026-10. Verfasst von David J. Leehey und 10 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Leehey, D. J., Agarwal, R., Xing, B., Clise, C. E., Navaneethan, S. D., Utzschneider, K. M., Lammie, D. E., Wei, Y., Polzin, L., Glomb, B. S., & Carlson, K. (2026). The Veterans Affairs Pentoxifylline in Diabetic Kidney Disease (VA PTXRx) Study: Baseline Characteristics. Journal of the American Society of Nephrology, 37(10S). https://doi.org/10.1681/asn.20268ctbde3b
Vancouver
Leehey DJ, Agarwal R, Xing B, Clise CE, Navaneethan SD, Utzschneider KM, et al. The Veterans Affairs Pentoxifylline in Diabetic Kidney Disease (VA PTXRx) Study: Baseline Characteristics. Journal of the American Society of Nephrology. 2026;37(10S). doi:10.1681/asn.20268ctbde3b
BibTeX
@article{Leehey2026,
author = {Leehey, David J. and Agarwal, Rajiv and Xing, Bin and Clise, Christina Elaine and Navaneethan, Sankar D. and Utzschneider, Kristina M. and Lammie, Douglas Edward and Wei, Yongliang and Polzin, Linda and Glomb, Blake Sterling and Carlson, Kimberly},
title = {The Veterans Affairs Pentoxifylline in Diabetic Kidney Disease (VA PTXRx) Study: Baseline Characteristics},
journal = {Journal of the American Society of Nephrology},
year = {2026},
volume = {37},
number = {10S},
doi = {10.1681/asn.20268ctbde3b}
}
EUVIMED